By drawing their Covid vaccines in less than a year, Moderna and BioNTech have knocked out Big Pharma.
Exit GSK, Sanofi and MSD, the world leaders in vaccines, excluded from the race after successive setbacks and delays.
The bet of the two biotechs on messenger RNA, a technology which had never yet led to the marketing of a product, was a winner.
Faced with the health emergency, this choice made it possible to go very quickly when it took until then ten years on average to develop a vaccine.
Read also
Vaccines: how BioNTech and Moderna are preparing for the post-Covid era
Moderna and BioNTech, who had been working on RNA for ten years, saw their tenacity rewarded.
But not only.
The risk taking was rewarded.
Thus Albert Bourla, the boss of Pfizer, dared to bet on a biotech (BioNtech) which had never yet proven itself.
Conversely, Sanofi, GSK and MSD have in turn declined the advances of Moderna, which offered them to team up on messenger RNA.
The French laboratory, which has joined forces with the British GSK on the Covid vaccine…
This article is for subscribers only.
You have 64% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for 1€ the first month
I ENJOY IT
Already subscribed?
Login
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/MTOHBDDWPFDTPBEOJ4TEBMTRWA.jpg)
